Randomized double-blind study with prednisone in Sydenham's chorea

Pediatric Neurology
José A PazM J Marques-Dias

Abstract

In this randomized, double-blind, parallel study of a group of 22 children and teenagers, prednisone efficacy in acute Sydenham's chorea was assessed. Use of prednisone (2 mg/kg/day during 4 weeks, followed by a gradual discontinuation) in the 22 patients and in a placebo group (n = 15) was evaluated by a chorea intensity score based on presence, distribution, and interference of choreic movement on daily activities. Each patient was evaluated by the same pediatric neurologist weekly during the first month, followed by evaluation on weeks 8 and 12, with further evaluations as necessary if choreic movements persisted. Although initial chorea intensity was similar in both groups, a significant difference was observed after 1 week of medication (P < 0.001) with a larger reduction in the prednisone group, that continued until the end of the study. Percentage decrease in chorea intensity scale score also was persistently and significantly (P < 0.001) greater in the prednisone group. Chorea complete remission time with prednisone (mean 54.3 days) was significantly shorter (P < 0.001) when compared with the placebo group (mean 119.9 days). Seven patients presented recurrences, with no difference between groups (13.6% and 26.7% in the ...Continue Reading

References

Jan 1, 1978·Archives of Neurology·L N Green
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·J N Caviness, M D Muenter
Mar 1, 1980·Neurology·P A NausiedaH L Klawans
Sep 26, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·F CardosoC C Mota
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·F CardosoS V Amaral
Jun 18, 2002·Arquivos de neuro-psiquiatria·Alexandra Prufer de Queiroz Campos AraujoHeber Souza Maia Filho
Sep 1, 1958·Annals of the Rheumatic Diseases·R A HITCHENS
Nov 26, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Francisco CardosoGuilherme Valença
Apr 1, 1952·Archives of Disease in Childhood·A DIXON, E G L BYWATERS
Aug 18, 2004·Archives of Neurology·Isabelle Korn-LubetzkiIsrael Steiner
Sep 21, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·N A HarrisonG Giovannoni
May 4, 1950·The New England Journal of Medicine·B F MASSELLE CRAIGE
Feb 26, 2005·Pediatric Neurology·Judith BarashAbraham Matitiau
Jun 23, 2005·Journal of Child Neurology·Marjorie A GarveySusan E Swedo

❮ Previous
Next ❯

Citations

Aug 29, 2012·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Hakan GumusNazmi Narin
Mar 30, 2010·European Journal of Pediatrics·Tabitha D van ImmerzeelNico G Hartwig
Apr 10, 2013·Current Infectious Disease Reports·Judith Barash
Jun 27, 2008·Current Treatment Options in Neurology·Francisco Cardoso
Jun 8, 2011·Journal of Molecular Neuroscience : MN·Hilla Ben-PaziDaniel Offen
Jul 3, 2010·Pediatrics in Review·Jonathan W Mink, Samuel H Zinner
Mar 10, 2011·Clinical Epidemiology·Michael D Seckeler, Tracey R Hoke
Jul 7, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·V BrousseV Abadie
May 18, 2016·Nature Reviews. Disease Primers·Jonathan R CarapetisLiesl Zühlke
Dec 27, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Carlo FuscoElvio Della Giustina
Aug 13, 2015·Human Vaccines & Immunotherapeutics·Giovanna VitalitiRaffaele Falsaperla
Jun 19, 2008·Brain & Development·Neil Gordon
Nov 24, 2007·The Journal of Pediatrics·Adrianne R WalkerJames F Bale
Oct 11, 2014·Brain Research·Kyle A Williams, Susan E Swedo
Aug 13, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·F J KirkhamC M Kipps
Jan 24, 2007·Parkinsonism & Related Disorders·Vitor TumasRegina Maria França Fernandes
Nov 7, 2016·European Journal of Pediatrics·Urška KočevarTadej Avčin
Aug 27, 2011·Journal of Child Neurology·Kathleen WalkerJo M Wilmshurst
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Kathleen G Walker, Jo M Wilmshurst
Jul 9, 2008·Current Opinion in Neurology·David S Wolf, Harvey S Singer
Oct 27, 2017·Cardiology in the Young·Renato P A TorresRosângela S L A Torres
May 29, 2015·The Cochrane Database of Systematic Reviews·Antoinette CilliersHaroon Saloojee
May 29, 2020·Clinical Pediatrics·Nicholas L NewcombRussell W Steele
Nov 10, 2017·Expert Review of Neurotherapeutics·H Bashir, J Jankovic
Jan 24, 2019·International Journal of Molecular Sciences·Giovanna FerraraRolando Cimaz
Jan 23, 2020·European Journal of Pediatrics·Elena FavarettoAndrea Taddio
Oct 13, 2019·Pediatric Neurology·Sanem Yilmaz, Jonathan W Mink
Jun 15, 2020·The Journal of Pediatrics·Marc A DelaneyNada Harik
Aug 7, 2021·Expert Review of Neurotherapeutics·Antonio L TeixeiraHarvey Singer
Jun 27, 2009·Neurologic Clinics·Francisco Cardoso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Francisco CardosoGuilherme Valença
Parkinsonism & Related Disorders
Antônio L Teixeira JrFrancisco Cardoso
© 2022 Meta ULC. All rights reserved